242 related articles for article (PubMed ID: 20044087)
1. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
Pelliccia F; Pasceri V; Cianfrocca C; Vitale C; Speciale G; Gaudio C; Rosano GM; Mercuro G
Atherosclerosis; 2010 Jun; 210(2):510-5. PubMed ID: 20044087
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan improves endothelial function in patients with essential hypertension.
Benndorf RA; Appel D; Maas R; Schwedhelm E; Wenzel UO; Böger RH
J Cardiovasc Pharmacol; 2007 Oct; 50(4):367-71. PubMed ID: 18049303
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome.
Porto I; Di Vito L; De Maria GL; Dato I; Tritarelli A; Leone AM; Niccoli G; Capogrossi MC; Biasucci LM; Crea F
Am J Cardiol; 2009 Jun; 103(11):1500-5. PubMed ID: 19463506
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.
Lake JE; Seang S; Kelesidis T; Currier JS; Yang OO
HIV Clin Trials; 2016 Nov; 17(6):225-232. PubMed ID: 27658740
[TBL] [Abstract][Full Text] [Related]
6. AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
Bellien J; Iacob M; Eltchaninoff H; Bourkaib R; Thuillez C; Joannides R
Clin Sci (Lond); 2007 Jun; 112(7):393-401. PubMed ID: 17125466
[TBL] [Abstract][Full Text] [Related]
7. Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease.
Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Fong DY; Lee SW; Li SW; Tam S; Lau CP; Tse HF
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):464-71. PubMed ID: 19587603
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease.
Zankl AR; Ivandic B; Andrassy M; Volz HC; Krumsdorf U; Blessing E; Katus HA; Tiefenbacher CP
Clin Res Cardiol; 2010 Dec; 99(12):787-94. PubMed ID: 20614124
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
Endtmann C; Ebrahimian T; Czech T; Arfa O; Laufs U; Fritz M; Wassmann K; Werner N; Petoumenos V; Nickenig G; Wassmann S
Hypertension; 2011 Sep; 58(3):394-403. PubMed ID: 21825227
[TBL] [Abstract][Full Text] [Related]
10. Effects of losartan on the mobilization of endothelial progenitor cells and improvement of endothelial function.
Tan H; Li X; Chen W; Chen Y; Wei X; Yang Y; Zhang H; Jin Q
Ann Clin Lab Sci; 2013; 43(4):402-6. PubMed ID: 24247796
[TBL] [Abstract][Full Text] [Related]
11. Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertension.
Syrbe U; Moebes A; Scholze J; Swidsinski A; Dörffel Y
Hypertens Res; 2007 Jun; 30(6):521-8. PubMed ID: 17664855
[TBL] [Abstract][Full Text] [Related]
12. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Sawada K
Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
[TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
[TBL] [Abstract][Full Text] [Related]
14. Effects of AT1 receptor antagonism with candesartan on endothelial function in patients with hypertension and coronary artery disease.
Perrone-Filardi P; Corrado L; Brevetti G; Silvestro A; Dellegrottaglie S; Cafiero M; Caiazzo G; Petretta A; Maglione A; Monda C; Guerra G; Marzano A; Cesarano P; Gargiulo P; Chiariello M
J Clin Hypertens (Greenwich); 2009 May; 11(5):260-5. PubMed ID: 19534023
[TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
Werner C; Kamani CH; Gensch C; Böhm M; Laufs U
Diabetes; 2007 Oct; 56(10):2609-15. PubMed ID: 17623816
[TBL] [Abstract][Full Text] [Related]
16. Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis--influence on IP-10, TNF-α and MCP-1.
Klinghammer L; Urschel K; Cicha I; Lewczuk P; Raaz-Schrauder D; Achenbach S; Garlichs CD
Cytokine; 2013 May; 62(2):290-6. PubMed ID: 23541900
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
[TBL] [Abstract][Full Text] [Related]
18. Relationship of depression, stress and endothelial function in stable angina patients.
Chen H; Zhang L; Zhang M; Song X; Zhang H; Liu Y; Lv S
Physiol Behav; 2013 Jun; 118():152-8. PubMed ID: 23688945
[TBL] [Abstract][Full Text] [Related]
19. Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.
Wago T; Yoshimoto T; Akaza I; Tsuchiya K; Izumiyama H; Doi M; Hirata Y
Hypertens Res; 2010 Aug; 33(8):796-801. PubMed ID: 20555330
[TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
